Amphetamines: a current epidemic.
作者信息
Miller Norman
机构信息
Medical College of Georgia, Augusta University, Augusta, GA, United States.
出版信息
Front Psychiatry. 2025 Mar 25;16:1460341. doi: 10.3389/fpsyt.2025.1460341. eCollection 2025.
Abstract
摘要
相似文献
1
Amphetamines: a current epidemic.
Front Psychiatry. 2025 Mar 25;16:1460341. doi: 10.3389/fpsyt.2025.1460341. eCollection 2025.
2
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Cochrane Database Syst Rev. 2016 Feb 4;2(2):CD009996. doi: 10.1002/14651858.CD009996.pub2.
3
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3.
4
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.
Cochrane Database Syst Rev. 2011 Jun 15(6):CD007813. doi: 10.1002/14651858.CD007813.pub2.
5
The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?
CNS Drugs. 2012 Mar 1;26(3):245-68. doi: 10.2165/11599630-000000000-00000.
6
[The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Z Kinder Jugendpsychiatr Psychother. 2012 Sep;40(5):287-99; quiz 299-300. doi: 10.1024/1422-4917/a000185.
7
Habituation and addiction to amphetamines.
Br Med J. 1962 Jul 7;2(5296):40-3. doi: 10.1136/bmj.2.5296.40.
8
ADDICTION TO AMPHETAMINES.
Br Med J. 1963 Nov 9;2(5366):1204. doi: 10.1136/bmj.2.5366.1204-a.
9
Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder.
J Neurosci. 2023 Oct 11;43(41):6898-6908. doi: 10.1523/JNEUROSCI.0982-23.2023. Epub 2023 Sep 4.
10
ADDICTION TO AMPHETAMINE.
Br Med J. 1963 Dec 14;2(5371):1536. doi: 10.1136/bmj.2.5371.1536-b.
本文引用的文献
1
Adverse Effects of Stimulant Interventions for Attention Deficit Hyperactivity Disorder (ADHD): A Comprehensive Systematic Review.
Cureus. 2023 Sep 26;15(9):e45995. doi: 10.7759/cureus.45995. eCollection 2023 Sep.
2
Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use.
Front Psychiatry. 2022 Jul 6;13:918197. doi: 10.3389/fpsyt.2022.918197. eCollection 2022.
3
Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study.
EClinicalMedicine. 2022 Jul 1;50:101524. doi: 10.1016/j.eclinm.2022.101524. eCollection 2022 Aug.
4
Attention-Deficit/Hyperactivity Disorder Overdiagnosis and Overprescriptions: Medicalization of Distractions.
Mayo Clin Proc. 2022 Jul;97(7):1339-1344. doi: 10.1016/j.mayocp.2022.02.026.
5
Stimulant Usage by Medical Students for Cognitive Enhancement: A Systematic Review.
Cureus. 2021 May 22;13(5):e15163. doi: 10.7759/cureus.15163.
6
Attention deficit hyperactivity disorder and comorbidity: A review of literature.
World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420.
7
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.
8
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States.
JAMA Netw Open. 2018 Oct 5;1(6):e183758. doi: 10.1001/jamanetworkopen.2018.3758.
9
Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016.
PLoS One. 2018 Nov 28;13(11):e0206100. doi: 10.1371/journal.pone.0206100. eCollection 2018.
10
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
Zotero 插件